108 related articles for article (PubMed ID: 11004699)
1. Clonal patterns in phaeochromocytomas and MEN-2A adrenal medullary hyperplasias: histological and kinetic correlates.
Diaz-Cano SJ; de Miguel M; Blanes A; Tashjian R; Galera H; Wolfe HJ
J Pathol; 2000 Oct; 192(2):221-8. PubMed ID: 11004699
[TBL] [Abstract][Full Text] [Related]
2. Genotype-Phenotype Correlation in Indian Patients with MEN2-Associated Pheochromocytoma and Comparison of Clinico-Pathological Attributes with Apparently Sporadic Adrenal Pheochromocytoma.
Rajan S; Zaidi G; Agarwal G; Mishra A; Agarwal A; Mishra SK; Bhatia E
World J Surg; 2016 Mar; 40(3):690-6. PubMed ID: 26438242
[TBL] [Abstract][Full Text] [Related]
3. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
[TBL] [Abstract][Full Text] [Related]
4. Adrenal medullary hyperplasia is a precursor lesion for pheochromocytoma in MEN2 syndrome.
Korpershoek E; Petri BJ; Post E; van Eijck CH; Oldenburg RA; Belt EJ; de Herder WW; de Krijger RR; Dinjens WN
Neoplasia; 2014 Oct; 16(10):868-73. PubMed ID: 25379023
[TBL] [Abstract][Full Text] [Related]
5. Multiple endocrine neoplasia 2 (MEN 2)/MEN 2A (Sipple syndrome).
Kousseff BG
Dermatol Clin; 1995 Jan; 13(1):91-7. PubMed ID: 7712656
[TBL] [Abstract][Full Text] [Related]
6. Over-diagnosis of potential malignant behavior in MEN 2A-associated pheochromocytomas using the PASS and GAPP algorithms.
Stenman A; Zedenius J; Juhlin CC
Langenbecks Arch Surg; 2018 Sep; 403(6):785-790. PubMed ID: 29779047
[TBL] [Abstract][Full Text] [Related]
7. Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors.
Komminoth P; Roth J; Schröder S; Saremaslani P; Heitz PU
Lab Invest; 1995 Apr; 72(4):424-31. PubMed ID: 7723281
[TBL] [Abstract][Full Text] [Related]
8. [112 cases of sporadic and genetically determined pheochromocytoma: a comparative pathologic study].
Gosset P; Lecomte-Houcke M; Duhamel A; Labat-Moleur F; Patey M; Floquet J; Viennet G; Berger-Dutrieux N; Caillou B; Franc B
Ann Pathol; 1999 Dec; 19(6):480-6. PubMed ID: 10617804
[TBL] [Abstract][Full Text] [Related]
9. Clonality as expression of distinctive cell kinetics patterns in nodular hyperplasias and adenomas of the adrenal cortex.
Díaz-Cano SJ; de Miguel M; Blanes A; Tashjian R; Galera H; Wolfe HJ
Am J Pathol; 2000 Jan; 156(1):311-9. PubMed ID: 10623680
[TBL] [Abstract][Full Text] [Related]
10. Topographic molecular profile of pheochromocytomas: role of somatic down-regulation of mismatch repair.
Blanes A; Sanchez-Carrillo JJ; Diaz-Cano SJ
J Clin Endocrinol Metab; 2006 Mar; 91(3):1150-8. PubMed ID: 16394087
[TBL] [Abstract][Full Text] [Related]
11. Molecular abnormalities in tumors associated with multiple endocrine neoplasia type 2.
Nelkin BD; Ball DW; Baylin SB
Endocrinol Metab Clin North Am; 1994 Mar; 23(1):187-213. PubMed ID: 7913025
[TBL] [Abstract][Full Text] [Related]
12. Clonal analysis of sporadic pancreatic endocrine tumours.
Perren A; Roth J; Muletta-Feurer S; Saremaslani P; Speel EJ; Heitz PU; Komminoth P
J Pathol; 1998 Dec; 186(4):363-71. PubMed ID: 10209484
[TBL] [Abstract][Full Text] [Related]
13. Frequent promoter methylation of tumor-related genes in sporadic and men2-associated pheochromocytomas.
Dammann R; Schagdarsurengin U; Seidel C; Trümpler C; Hoang-Vu C; Gimm O; Dralle H; Pfeifer GP; Brauckhoff M
Exp Clin Endocrinol Diabetes; 2005 Jan; 113(1):1-7. PubMed ID: 15662588
[TBL] [Abstract][Full Text] [Related]
14. Adrenomedullary hyperplasia and phaeochromocytoma. DNA cytophotometric findings in 47 cases.
Padberg BC; Garbe E; Achilles E; Dralle H; Bressel M; Schröder S
Virchows Arch A Pathol Anat Histopathol; 1990; 416(5):443-6. PubMed ID: 2107632
[TBL] [Abstract][Full Text] [Related]
15. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
[TBL] [Abstract][Full Text] [Related]
16. Contribution of the microvessel network to the clonal and kinetic profiles of adrenal cortical proliferative lesions.
Diaz-Cano SJ; de Miguel M; Blanes A; Galera H; Wolfe HJ
Hum Pathol; 2001 Nov; 32(11):1232-9. PubMed ID: 11727263
[TBL] [Abstract][Full Text] [Related]
17. Intra-tumoral molecular heterogeneity in benign and malignant pheochromocytomas and extra-adrenal sympathetic paragangliomas.
Korpershoek E; Stobbe CK; van Nederveen FH; de Krijger RR; Dinjens WN
Endocr Relat Cancer; 2010 Sep; 17(3):653-62. PubMed ID: 20488782
[TBL] [Abstract][Full Text] [Related]
18. Multiple endocrine neoplasia (MEN)--an overview and case report--patient with sporadic bilateral pheochromocytoma, hyperparathyroidism and marfanoid habitus.
Fassbender WJ; Krohn-Grimberghe B; Görtz B; Litzlbauer D; Stracke H; Raue F; Kaiser HE
Anticancer Res; 2000; 20(6C):4877-87. PubMed ID: 11205236
[TBL] [Abstract][Full Text] [Related]
19. Multiple endocrine neoplasia type 2 and the RET protooncogene: from bedside to bench to bedside.
Machens A; Dralle H
Mol Cell Endocrinol; 2006 Mar; 247(1-2):34-40. PubMed ID: 16343738
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
